ogb.png
Orange Grove Bio Expands Academic Collaboration Activities Internationally Through New Strategic Partnerships
23 mars 2023 06h30 HE | Orange Grove Bio
CINCINNATI, March 23, 2023 (GLOBE NEWSWIRE) -- Orange Grove Bio, a drug investment and development firm, today announced that it has established new strategic collaborations with the Yonsei...
EvolveImmune Logo.jpg
EvolveImmune Therapeutics Presents New Preclinical Data Demonstrating Improved Anti-Tumor Potential of Novel Costimulatory T Cell Engager Platform at Festival of Biologics Immunotherapy World Congress
22 mars 2023 07h00 HE | EvolveImmune
Company Unveils EVOLVE-105 Program, A Best-in-Class CD20xCD3 Multispecific Antibody Designed to Concurrently Drive CD2 Costimulation to Improve the Treatment of B cell Malignancies Expanding...
image003
BrightInsight Named to Fierce Medtech’s 2022 Fierce 15 List
20 mars 2023 13h45 HE | BrightInsight
SAN JOSE, Calif., March 20, 2023 (GLOBE NEWSWIRE) -- BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solutions, announced today that...
POAI+CRHimage
Predictive Oncology and Cancer Research Horizons have partnered to pursue development of cancer drugs
17 mars 2023 07h00 HE | Predictive Oncology Inc.
EAGAN, Minn., March 17, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) together with Cancer Research Horizons, the innovation engine at the core of the world’s largest private...
Cellectis Logo.png
Monthly information on share capital and company voting rights
15 mars 2023 17h02 HE | Cellectis Inc.
NEW YORK, March 15, 2023 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 DateTotal number of sharesin the capitalTotal number of voting...
Cellectis Logo.png
Cellectis Announces Poster Presentation on TALEN®-edited MUC1 CAR T-cells Targeting Triple Negative Breast Cancer at the American Association of Cancer Research (AACR) Annual Meeting
14 mars 2023 17h00 HE | Cellectis Inc.
NEW YORK, March 14, 2023 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to...
Culture Biosciences Logo (no background).png
Culture Biosciences Focuses Technology and Service Platform on Biologics
14 mars 2023 08h00 HE | Culture Biosciences
San Francisco, March 14, 2023 (GLOBE NEWSWIRE) -- SAN FRANCISCO, March 14, 2023 (GLOBE NEWSWIRE) – Culture Biosciences today announced that it is increasing its focus on upstream bioprocess...
Logo.PNG
2023 SXSW Conference Hosts Psychedelic Healthcare VC Fund Palo Santo
09 mars 2023 10h19 HE | Palo Santo
CHICAGO and NEW YORK, March 09, 2023 (GLOBE NEWSWIRE) -- As therapeutic applications of psychedelics gain more traction in the mainstream consciousness, psychedelics are a major focus at SXSW 2023,...
Aseptic filling of small volumes at unprecedented filling accuracy
Aseptic Filling of Small Volumes at High Precision
09 mars 2023 09h00 HE | Single Use Support
KUFSTEIN, Austria, March 09, 2023 (GLOBE NEWSWIRE) -- Typically, the distribution of small volumes of advanced therapy medicinal products (ATMP) into small single-use bags was done manually....
RoSS.FILL Lab Scale offers unprecedented filling accuracy
Remplissage aseptique de petits volumes haute précision
09 mars 2023 09h00 HE | Single Use Support
KUFSTEIN, Autriche, 09 mars 2023 (GLOBE NEWSWIRE) -- Habituellement, la distribution de petits volumes de médicaments de thérapie innovante (ATMP) dans des petits sacs à usage unique s'effectuait...